Summary
- Current Price
- As of today, AXSM price is $234.58, down -0.59% in the most recent trading session on
- Current Price All-Time High
- AXSM price is currently -1.67% below its historical high of $238.56 set on
- Market Cap
- AXSM current market cap is $12B, up +133.34% over the past 365 days
- PE Ratio
- AXSM PE ratio is unknown
- Revenue
- AXSM current annual revenue is $638.50M, up +65.55% year-over-year
- Next Earnings
- The next earnings release for AXSM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Axsome Therapeutics, Inc. |
| Ticker | NASDAQ: AXSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | axsome.com |
| Employees | 712 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $234.58 | |
| Price, 1D Change | -0.59% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.67 | |
| Revenue | $638M | |
| Revenue, 1Y Change | +65.55% | |
| EPS | -$3.68 | |
| EPS, 1Y Change | +38.57% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.68 | |
| EPS Estimate | N/A | -$1.71 |
| EPS Est. Change | N/A | +53.66% |
| Revenue | $638.50M | |
| Revenue Estimate | N/A | $985.50M |
| Revenue Est. Change | N/A | +54.35% |
| Current Price | $234.58 | |
| Price Target | - | $272.00 |
| Price Tgt. Change | - | +15.95% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.15 | -$5.99 | -16.40% | |
| -$3.87 | -$3.68 | +4.84% | |
| -$1.71 | N/A | +53.66% | |
| $5.89 | N/A | +259.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $385.06M | $385.69M | +0.16% | |
| $635.84M | $638.50M | +0.42% | |
| $985.50M | N/A | +54.35% | |
| $1.59B | N/A | +149.60% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +123.26% | |
| Price, 3Y | +236.07% | |
| Market Cap, 1Y | +133.34% | |
| Market Cap, 3Y | +296.89% | |
| Revenue, 1Y | +65.55% | |
| Revenue, 3Y | +1,176.05% | |
| EPS, 1Y | +38.57% | |
| EPS, 3Y | +20.00% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $234.58 | |
| SMA 200 | $156.71 | |
| SMA 200 vs Price | -33.19% | |
| SMA 50 | $190.00 | |
| SMA 50 vs Price | -19.00% | |
| Beta | 0.67 | |
| ATR | $8.16 | |
| 14-Day RSI | 73.36 | |
| 10-Day Volatility | 34.31% | |
| 1-Year Volatility | 41.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $638.50M | |
| EPS | -$3.68 | |
| Gross Profit | $581.95M | |
| Gross Margin | 91.14% | |
| Operating Profit | -$169.24M | |
| Operating Margin | -26.51% | |
| Net Income | -$183.17M | |
| Net Margin | -28.69% | |
| EBITDA | -$160.17M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.47 | |
| 1.55 | ||
| 1.48 | ||
| - | ||
| 4 | ||
| 9.87 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 17.04 | ||
| 221.14 | ||
| -71.62 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $88.29M | |
| $322.93M | ||
| $689.81M | ||
| $588.99M | ||
| $601.51M | ||
| $378.84M | ||
| Total Debt | $218.11M | |
| $72.98M | ||
| $65.54M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $821.67M | ||
| $751.19M | ||
| $56.54M | ||
| $0.00 | ||
| $9.06M | ||
| $0.00 | ||
| -$530.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$93.41M | ||
| -$480.00K | ||
| $101.47M | ||
| Capex | $480.00K | |
| -$93.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| RBC Capital | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Baird | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AXSM
FAQ
What is the ticker symbol for Axsome Therapeutics, Inc.?
The ticker symbol for Axsome Therapeutics, Inc. is NASDAQ:AXSM
Does Axsome Therapeutics, Inc. pay dividends?
No, Axsome Therapeutics, Inc. does not pay dividends
What sector is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is in the Healthcare sector
What industry is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is in the Biotechnology industry
What country is Axsome Therapeutics, Inc. based in?
Axsome Therapeutics, Inc. is headquartered in United States
When did Axsome Therapeutics, Inc. go public?
Axsome Therapeutics, Inc. initial public offering (IPO) was on November 19, 2015
Is Axsome Therapeutics, Inc. in the S&P 500?
No, Axsome Therapeutics, Inc. is not included in the S&P 500 index
Is Axsome Therapeutics, Inc. in the NASDAQ 100?
No, Axsome Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Axsome Therapeutics, Inc. in the Dow Jones?
No, Axsome Therapeutics, Inc. is not included in the Dow Jones index
When was Axsome Therapeutics, Inc. last earnings report?
Axsome Therapeutics, Inc.'s most recent earnings report was on May 4, 2026
When does Axsome Therapeutics, Inc. report earnings?
The next expected earnings date for Axsome Therapeutics, Inc. is August 3, 2026
Data Sources & References
- AXSM Official Website www.axsome.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm
- AXSM Profile on Yahoo Finance finance.yahoo.com/quote/AXSM
- AXSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/axsm